This search function provides links to outputs produced by NIHR Innovation Observatory. These are briefing notes or reports on new or repurposed technologies. This search will not return all technologies currently in development as these outputs are produced as required for our stakeholders.

Innovation Observatory > Reports > Drugs > Cethrin for traumatic spinal cord injury

< Back

Cethrin for traumatic spinal cord injury


Neurology and Neurosurgery

September 2017

A traumatic cervical spinal cord injury results from trauma (such as a fall or car crash, rather than from a disease), and affects the spinal cord in the upper part of the spine (known as the cervical spine). The spinal cord is the bundle of nerves that runs down the middle of the back, and damage to these nerves disrupts how the brain and body communicate. This can result in a variety of complications including death, paralysis (loss of the ability to move one or more muscles) and breathing issues. Spinal cord injuries to the cervical spinal cord are the most severe of all spinal cord injuries. The risk of death is highest within the first year of injury.
Cethrin is being developed to treat traumatic cervical spinal cord injuries in adolescents and adults. The current treatment option for traumatic spinal cord injuries is methylprednisolone (a steroid) used to reduce inflammation. Surgery is an option in cases when the spinal fluid or tissue presses on the spinal cord. If marketed, Cethrin may help repair damaged nerve cells, allowing the brain and body to better communicate. This could help restore movement in patients with traumatic spinal cord injuries.

Innovation Observatory Voice 0

Leave a Reply

Your email address will not be published. Required fields are marked *

Post Comment


Connect to the Innovation Observatory


Load More Related Posts

Get Alerts